141 related articles for article (PubMed ID: 11068137)
1. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine.
Rabinovic AD; Lewis DA; Hastings TG
Neuroscience; 2000; 101(1):67-76. PubMed ID: 11068137
[TBL] [Abstract][Full Text] [Related]
2. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
Hastings TG; Lewis DA; Zigmond MJ
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1956-61. PubMed ID: 8700866
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
4. Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis.
Santiago M; Machado A; Cano J
J Neurosci Methods; 2001 Jul; 108(2):181-7. PubMed ID: 11478977
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous glutathione in the oxidation of dopamine.
Rabinovic AD; Hastings TG
J Neurochem; 1998 Nov; 71(5):2071-8. PubMed ID: 9798932
[TBL] [Abstract][Full Text] [Related]
6. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.
LaVoie MJ; Hastings TG
J Neurosci; 1999 Feb; 19(4):1484-91. PubMed ID: 9952424
[TBL] [Abstract][Full Text] [Related]
7. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
[TBL] [Abstract][Full Text] [Related]
8. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
Obata T; Yamanaka Y; Kinemuchi H; Oreland L
Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
[TBL] [Abstract][Full Text] [Related]
9. Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione.
Hastings TG; Zigmond MJ
J Neurochem; 1994 Sep; 63(3):1126-32. PubMed ID: 8051554
[TBL] [Abstract][Full Text] [Related]
10. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
11. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
12. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
Ali SF; David SN; Newport GD; Cadet JL; Slikker W
Synapse; 1994 Sep; 18(1):27-34. PubMed ID: 7825121
[TBL] [Abstract][Full Text] [Related]
13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
14. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
15. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.
Clark J; Clore EL; Zheng K; Adame A; Masliah E; Simon DK
PLoS One; 2010 Aug; 5(8):e12333. PubMed ID: 20808797
[TBL] [Abstract][Full Text] [Related]
16. Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures.
Moy LY; Zeevalk GD; Sonsalla PK
J Neurochem; 2000 Apr; 74(4):1656-65. PubMed ID: 10737624
[TBL] [Abstract][Full Text] [Related]
17. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
Pu C; Fisher JE; Cappon GD; Vorhees CV
Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636
[TBL] [Abstract][Full Text] [Related]
18. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
19. Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle.
Ueda S; Aikawa M; Ishizuya-Oka A; Yamaoka S; Koibuchi N; Yoshimoto K
Neuroscience; 2000; 95(2):389-98. PubMed ID: 10658618
[TBL] [Abstract][Full Text] [Related]
20. Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.
Lonjon M; Quentien MH; Risso JJ; Michiels JF; Carre E; Rostain JC; Darbin O
Neurosci Lett; 2004 Jan; 354(2):131-4. PubMed ID: 14698456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
